Dimensional Fund Advisors LP Pacira Bio Sciences, Inc. Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,163,473 shares of PCRX stock, worth $51.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,163,473

Previous 2,151,642 0.55%

Holding current value

$51.4 Million

Previous $51.4 Million 8.42%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$21.09 - $27.22 $249,515 - $322,039	11,831 Added 0.55%	2,163,473 $55.8 Million
Q2 2025 Aug 12, 2025	BUY	$22.91 - $27.14 $2.34 Million - $2.77 Million	102,211 Added 4.99%	2,151,642 $51.4 Million
Q1 2025 May 13, 2025	BUY	$18.33 - $27.25 $3.98 Million - $5.92 Million	217,215 Added 11.86%	2,049,431 $50.9 Million
Q4 2024 Feb 13, 2025	SELL	$15.3 - $20.33 $614,356 - $816,330	-40,154 Reduced 2.14%	1,832,216 $34.5 Million
Q3 2024 Nov 07, 2024	BUY	$11.7 - $28.46 $518,368 - $1.26 Million	44,305 Added 2.42%	1,872,370 $28.2 Million
Q2 2024 Aug 09, 2024	BUY	$25.5 - $31.51 $5.07 Million - $6.27 Million	198,936 Added 12.21%	1,828,065 $52.3 Million
Q1 2024 May 10, 2024	BUY	$27.7 - $35.48 $6.02 Million - $7.71 Million	217,362 Added 15.4%	1,629,129 $47.6 Million
Q4 2023 Feb 07, 2024	BUY	$26.32 - $34.31 $472,417 - $615,830	17,949 Added 1.29%	1,411,767 $47.6 Million
Q3 2023 Nov 09, 2023	BUY	$30.68 - $40.09 $8.33 Million - $10.9 Million	271,544 Added 24.2%	1,393,818 $42.8 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $47.5 $4.81 Million - $6.32 Million	133,097 Added 13.46%	1,122,274 $45 Million
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $1.49 Million - $1.81 Million	41,808 Added 4.41%	989,177 $40.4 Million
Q4 2022 Feb 09, 2023	BUY	$38.19 - $57.45 $2.68 Million - $4.03 Million	70,141 Added 8.0%	947,369 $36.6 Million
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $3.48 Million - $4 Million	67,892 Added 8.39%	877,228 $46.7 Million
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $2.62 Million - $4.16 Million	50,941 Added 6.72%	809,336 $47.2 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $216,228 - $275,516	3,602 Added 0.48%	758,395 $57.9 Million
Q4 2021 Feb 09, 2022	BUY	$47.97 - $62.21 $1.93 Million - $2.5 Million	40,191 Added 5.62%	754,793 $45.4 Million
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $3.73 Million - $4.19 Million	-68,290 Reduced 8.72%	714,602 $40 Million
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $10 Million - $11.9 Million	169,324 Added 27.6%	782,892 $47.5 Million
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $2.24 Million - $2.98 Million	37,851 Added 6.57%	613,568 $43 Million
Q4 2020 Feb 25, 2021	BUY	$50.47 - $66.26 $29.1 Million - $38.1 Million	575,717 New	575,717 $34.4 Million

Others Institutions Holding PCRX

# of Institutions

262

Shares Held

48.9M

Call Options Held

118K

Put Options Held

63.7K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Pacira Bio Sciences, Inc. Transaction History